NASDAQ: TARS
Tarsus Pharmaceuticals Inc Earnings Dates, Reports, Calls

Tarsus Pharmaceuticals earnings were -$115.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TARS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$23.1M, down 1.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TARS reported annual earnings of -$115.6M, with -15% growth. The next TARS earnings date is May 6, 2025.

TARS earnings history

Current Revenue
$183.0M
Current Earnings
-$115.6M
Current Profit Margin
-63.2%

TARS Return on Equity

Current Company
-46.7%
Current Industry
-2%
Current Market
34.1%
TARS's Return on Equity (-46.7%)... subscribe to Premium to read more.
High Return on Equity Performance

TARS undefined

Current Company
-31.2%
Current Industry
-0.4%
TARS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TARS announces earnings.

TARS undefined

Current Company
-36.34%
Current Industry
5.9%
TARS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TARS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TARS-$105.85M-$115.55MN/A-$3.07
MIRM-$47.62M-$87.94MN/A-$1.85
DNLI-$413.71M-$422.77MN/A-$2.57
NAMS-$254.20M-$254.31MN/A-$2.70
APGE-$180.25M-$182.15MN/A-$3.30

TARS earnings dates

Next earnings date
May 6, 2025

Tarsus Pharmaceuticals Earnings Reports & History FAQ

What were Tarsus Pharmaceuticals's earnings last quarter?

On TARS's earnings call on Invalid Date, Tarsus Pharmaceuticals (NASDAQ: TARS) reported Q4 2024 earnings per share (EPS) of -$0.59, up 53.54% year over year. Total TARS earnings for the quarter were -$23.11 million. In the same quarter last year, Tarsus Pharmaceuticals's earnings per share (EPS) was -$1.27.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.

When does Tarsus Pharmaceuticals report earnings?

The next TARS earnings date is Invalid Date. Add TARS to your watchlist to be reminded of Tarsus Pharmaceuticals's next earnings date.

What was TARS's earnings growth in the past year?

As of Tarsus Pharmaceuticals's earnings date in Invalid Date, Tarsus Pharmaceuticals's earnings has grown year over year. TARS earnings in the past year totalled -$115.55 million.

Is Tarsus Pharmaceuticals profitable or losing money?

As of the last Tarsus Pharmaceuticals earnings report, Tarsus Pharmaceuticals is currently losing money. Tarsus Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$115.55 million, a 14.97% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.